Sunlight, cholesterol and coronary heart disease

QJM: An International Journal of Medicine

Volumn 89, Issue 8, 1996, Pages 579-589

  Grimes, D S ^a   Hindle, E ^a   Dyer, T ^a  

^a ROYAL BLACKBURN HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; VITAMIN D;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL SYNTHESIS; GEOGRAPHY; HUMAN; INCIDENCE; ISCHEMIC HEART DISEASE; MALE; METABOLISM; MORBIDITY; PRIORITY JOURNAL; SEASONAL VARIATION; SUMMER; SUNLIGHT; VITAMIN BLOOD LEVEL; WINTER;

EID: 0029758228     PISSN: 00335622     EISSN: None     Source Type: Journal    
DOI: 10.1093/qjmed/89.8.579     Document Type: Article

References (53)

1. Fleck A. Latitude and ischaemic heart disease. Lancet 1989; i:13.
2. Sinclair H. Latitude and ischaemic heart disease. Lancet 1989; i:895.
3. Barker DJP. Geographical variations in disease in Britain. Br Med J 1981; 283:398-400.
4. Elford J, Phillips AN, Thomson AG, Shaper AG. Migration and geographical variations in ischaemic heart disease in Great Britain. Lancet 1989; i:343-6.
5. Gyllerup S, Lanke J, Lindholm LH, Schersten B. Smoking habits, sales of fat and antihypertensives fail to explain the high coronary mortality in cold regions of Sweden. Scot Med J 1991; 36:165-8.
6. Fabsitz R, Feinleib M. Geographic patterns in country mortality rates from cardiovascular diseases. Am J Epidemiol 1980; 111:315-28.
7. Mortimer EA, Monson MD, MacMahon B. Reduction in mortality from coronary heart disease in men residing at high altitude. N Engl J Med 1977; 296:581-5.
8. Voors AW, Johnson WD. Altitude and arteriosclerotic heart disease mortality in white residents of 99 of the 100 largest cities in the United States. J Chronic Dis 1979; 32:157-62.
9. Martin MJ, Hulley SB, Browner WS, Kuller LH, Wentworth D. Serum cholesterol, blood pressure, and mortality: implications from a cohort of 361 662 men. Lancet 1986;ii:933-6.
10. Rose G, Shipley M. Plasma cholesterol concentration and death from coronary heart disease: 10 year results of the Whitehall study. Br Med J 1986; 293:306-7.
11. ROSSOUW JE, Lewis B, Rifkind BM. The value of lowering cholesterol after myocardial infarction. N Engl J Med 1990; 323:1112-19.
12. The Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344:1383-9.
13. Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, Macfarlane PW, McKillop JH, Packhard CJ, for the West of Scotland Coronary Prevention Study Group. Prevention of coronary heart disease with pravastatin in men with hypercholesterolaemia. N Engl J Med 1995; 333:1301-7.
14. Muldoon MF, Manuck SB, Matthews KA. Lowering cholesterol concentrations and mortality: a quantitative review of primary prevention trials. Br Med J 1990; 301:309-14.
15. Ravnskov U. Cholesterol lowering trials in coronary heart disease: frequency of citation and outcome. Br Med J 1992; 305:15-19.
16. Keys A. Seven Countries - a multivariate analysis of death and coronary heart disease. Cambridge MA and London, Harvard University Press, 1980.
17. Myant NB. The Biology of Cholesterol and Related Steroids. London William Heinmann Medical Books, 1981.
18. Gordon DJ, Hyde J, Trost DC, Whaley FS, Hannan PJ, Jacobs DR, Ekelund L-G. Cyclic seasonal variation in plasma lipid and lipoprotein levels: the lipid research clinics coronary primary prevention trial placebo group. J Clin Epidemiol 1988; 41:679-89.
19. Lancet (Editorial). Vitamin C and plasma cholesterol. Lancet 1984; ii:907.
20. Skrabanek P. The Death of Humane Medicine and the Rise of Coercive Healthism. The Social Affairs Unit, 1994.
21. Cade JE, Barker DJP, Margetts BM, Morris JA. Diet and inequalities in health in three English towns. Br Med J 1988; 296:1359-62.
22. Evans AE, Ruidavets J-B, McCrum E, Cambou J-P, McClean R, Douste-Blazy P, McMaster D, Bingham A, Patterson CC, Richard JL, Mathewson ZM, Cambien F. Autres pays, autres coeurs? Dietary patterns, risk factors and ischaemic heart disease in Belfast and Toulouse (WHO MONICA project). Q J Med 1995; 88:469-77.
23. Paterson D. Did Tibet cool the world? New Scientist 1993; 3 July:29-33.
24. Blackburn, Hyndburn and Ribble Valley Health Authority. Public Health Report-1992.
25. Marmot MG, Shipley MJ, Rose G. Inequalities in death - specific explanations of a general pattern? Lancet 1984; ii:1003-6.
26. Balarajan R. Inequalities in health within the health sector. Br Med J 1989; 299:822-5.
27. Rosengren A, Wedel H, Wilhelmsen L. Coronary heart disease and mortality in middle aged men from different occupational classes in Sweden. Br Med J 1988; 297:1497-500.
28. Health Education Authority. Health Update. 5: Physical Activity. 1995.
29. McKeigue PM, Marmot MG. Mortality from coronary heart disease in Asian communities in London. Br Med J 1988; 297:903.
30. Hughes LO, Raval U, Raftery EB. First myocardial infarctions in Asian and white men. Br Med J 1989; 298:1345-50.
31. Balarajan R. Ethnic differences in mortality from ischaemic heart disease and cerebrovascular disease in England and Wales. Br Med J 1991; 302:560-4.
32. Smith R. Asian rickets and osteomalacia. Q J Med 1990; 76:899-901.
33. Finch PJ, Millard FJC, Maxwell JD. Risk of tuberculosis in immigrant Asians: culturally acquired immunodeficiency? Thorax 1991; 46:1-5.
34. Finch PJ, Ang L, Eastwood JB, Maxwell JD. Clinical and histological spectrum of osteomalacia among Asians in South London. Q J Med 1992; 83:439-48.
35. Kannel WB, Thom TJ. Declining cardiovascular mortality. Circulation 1984; 70:331-6.
36. Stamler J. The marked decline in coronary heart disease mortality rates in the United States, 1968-1981; summary of findings and possible explanations. Cardiology 1985; 72:11-22.
37. Wilmshurst P. Temperature and cardiovascular mortality. Br Med J 1994; 309:1029-30.
38. Dockery DW, Pope III, CA, Xu X, Spengler JD, Ware JH, Fay ME, Ferris BG, Speizer FE. An association between air pollution and mortality in six US cities. N Engl J Med 1993; 329:1753-9.
39. Webb AR, Kline L, Holick MF. Influence of season and latitude on the cutaneous synthesis of vitamin D3: exposure to winter sunlight in Boston and Edmondton will not promote vitamin D3 synthesis in human skin. J Clin Endocrinol Metab 1988; 67:373-7.
40. Healy B. Endothelial cell dysfunction: an emerging endocrinopathy linked to coronary disease. J Am Coll Cardiol 1990; 16:357-8.
41. Celemajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan JK, Lloyd JK, Deanfield JE. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992; 340:1111-15.
42. Collins P. Coronary artery endothelium in ischaemia. In Anderson RH, Poole-Wilson PA, Yacoub MH, eds. Atheroma to Heart Failure: A Continuum of Disease? London, Butterworth Heinemann, 1991.
43. Barker JPD. The intrauterine origins of cardiovascular and obstructive lung disease in adult life. J Roy Coll Phys London 1991; 25:129-33.
44. Strachan DP, Powell KJ, Thacker A, Millard FJC, Maxwell JD. Vegetarian diet as a risk factor for tuberculosis in immigrant south London Asians. Thorax 1995; 50:173-80.
45. Ross R. The pathogenesis of arteriosclerosis: a perspective for the 1990s. Nature 1993; 362:801-9.
46. Saikku P, Leinonen M, Mattila K, Eckman MR, Nieminen MS, Mäkelä PH, Huttunen JK, Valtonen V. Serological evidence of an association of a novel chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 1988; ii:983-6.
47. Saikku P, Leiononen M, Tenkanen L, Linnanmaki E, Ekman M, Manninen M, Månttåri M, Frick NH, Huttunen JK. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki heart study. Ann Intern Med 1992; 116:273-7.
48. Kuo CC, Shor A, Campbell LA, Fukushi H, Patton DL, Grayston JT. Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. J Infect Dis 1993; 167:841-9.
49. Patel P, Mendall MA, Carrington D, Stachan DP, Leatham E, Molineaux N, Levy J, Blakeston C, Seymour CA, Camm AJ, Northfeld TC. Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors. Br Med J 1995; 311:711-14.
50. Tsianos EV, Masalas CN, Merkouropoulos M, Dalekos GN, Logan RFA. Incidence of inflammatory bowel disease in north west Greece: rarity of Crohn's disease in an area where ulcerative colitis is common. Gut 1994; 35:369-72.
51. Sanderson JD, Moss MT, Tizard MLV, Hermon-Taylor J. Mycobacterium paratuberculosis DNA in Crohn's disease tissue. Gut 1992; 33:890-6.
52. Salonen JT, Alfthan G, Huttenen JK, Pikkarainen J, Puska P. Association between cardiovascular death and myocardial infarction and serum selenium in a matched-pair longitudinal study. Lancet 1982; ii:175-9.
53. de Bono DP. Free radicals and antioxidants in vascular biology: the roles of reaction kinetics, environment and substrate turnover. Q J Med 1994; 87:445-53.